Product Description
Cefotetan injection is used to treat infections of the lungs, skin, bones, joints, stomach area, blood, female reproductive organs, and urinary tract. Cefotetan injection is also used before surgery to prevent infections. Cefotetan injection is in a class of medications called cephalosporin antibiotics. It works by killing bacteria. (Sourced from: https://medlineplus.gov/druginfo/meds/a686015.html)
Mechanisms of Action: Cell Wall Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Intravenous
FDA Designation: None *
Approval Status: Approved
Approved Countries: Bangladesh | Canada | Egypt | Germany | Italy | Jordan | Korea | Morocco | New Zealand | Poland | Portugal | Taiwan | United States
Approved Indications: None
Known Adverse Events: None
Company: Chongqing Libang Drug Development Co., Ltd.
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic: China
Active Clinical Trial Count: 2
Highest Development Phases
Phase 2: Respiratory Tract Infections|Urinary Tract Infections
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|---|---|---|---|---|
CTR20132304 | P2 |
Recruiting |
Unknown |
None |
|
CTR20170101 | P2 |
Not yet recruiting |
Urinary Tract Infections|Respiratory Tract Infections |
None |